Glimicer MV 2 Tablet SR
Glimicer MV 2 Tablet SR
Introduction to Glimicer MV 2 Tablet SR
Glimicer MV 2 Tablet SR is a prescription-only medicine and is a potent triple drug combination formulated with Voglibose, Glimepiride, and Metformin hydrochloride to deliver effective control over Type II diabetes. This specialized medication is recommended for challenging cases, ensuring comprehensive management of diabetes.
Voglibose contributes by retarding the digestion and absorption of carbohydrates, Glimepiride stimulates insulin secretion, and Metformin Hydrochloride (SR) enhances insulin sensitivity. Together, they form a powerful trio targeting different aspects of glucose control, providing a multifaceted strategy against Type II diabetes.
Typically, it is taken orally, and the dosage may vary based on individual health parameters. It is often recommended to take the medication with a meal to optimize its effectiveness.
Users should be aware of potential side effects. These may include gastrointestinal discomforts such as diarrhea, abdominal pain, and nausea. Fluctuations in blood sugar levels and other reactions are possible Promptly report any adverse effects to your healthcare professional.
Individuals with specific health conditions, such as kidney or liver disorders, should exercise caution. Pregnant or breastfeeding individuals, as well as those with known allergies to any of the components, should consult their healthcare provider before starting this medication.
In the event of a missed dose, take it as soon as remembered unless it's close to the next scheduled dose. Do not double up to compensate for a missed dose.
Related Faqs
Are there any specific conditions in which Glimda-MV 2 Tablet SR should not be taken?
Patients who have a known allergy to any of the ingredients or excipients present in GlimdaMV 2 Tablet SR should refrain from using this medication It is similarly contraindicated for individuals with moderate to severe kidney disease Additionally patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis are also advised against taking this medicine Patients who have experienced an allergic reaction to GlimdaMV 2 Tablet SR or any of its components should avoid using this medication Furthermore individuals with significant kidney impairment should not take this medicine It is also not recommended for patients with inflammatory bowel disease colonic ulcerations or underlying metabolic acidosis such as diabetic ketoacidosis Those who have a known hypersensitivity to the ingredients or excipients in GlimdaMV 2 Tablet SR should refrain from using this medication Likewise individuals with moderate to severe kidney disease and patients with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine Patients who have a known allergy to any of the components or excipients of GlimdaMV 2 Tablet SR should refrain from using this medication Similarly individuals with moderate to severe kidney disease and patients who have inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should avoid taking this medicine It is imperative that patients who have a known allergic reaction to any of the ingredients or excipients of GlimdaMV 2 Tablet SR should avoid using this medication Additionally this medicine is not recommended for patients with moderate to severe kidney disease or those with inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis
What are the instructions for the storage and disposal of Glimda-MV 2 Tablet SR?
To ensure the effectiveness and safety of this medication it is crucial to store it appropriately Always keep the medicine in its original packet or container making sure to tightly close it after each use Follow the storage instructions provided on the packaging or label to maintain its stability and potency Proper storage conditions can vary depending on the medication so it is important to refer to the specific guidelines outlined When it comes to disposing of any unused medication take extra care to prevent accidental consumption by pets children or other individuals Safely discard the medicine in a responsible manner as per the recommended disposal procedures By practicing proper storage and disposal methods you can play an active role in promoting medication safety for both yourself and those around you
What is Glimda-MV 2 Tablet SR?
Glimda-MV 2 Tablet SR is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
What is Glimitip-MV?
GlimitipMV is a powerful combination of Glimepiride Metformin and Voglibose three potent medicines used for the treatment of type 2 diabetes mellitus DM Designed to improve blood glucose levels in adults this medication is an integral part of a comprehensive treatment plan that includes a balanced diet and regular exercise Glimepiride one of the active ingredients in GlimitipMV effectively lowers blood glucose levels by stimulating the pancreas to release more insulin This hormone plays a crucial role in regulating blood sugar levels Metformin another key component acts by reducing glucose production in the liver and improving insulin sensitivity further contributing to better glycemic control Voglibose the third ingredient in GlimitipMV is an alphaglucosidase inhibitor that efficiently lowers postprandial glucose levels By inhibiting the enzymes responsible for breaking down carbohydrates in the intestine Voglibose delays glucose absorption and helps maintain more stable blood sugar levels after meals It is important to note that GlimitipMV is specifically intended for the treatment of type 2 diabetes mellitus and should not be used for type 1 diabetes As a comprehensive combination medication GlimitipMV offers a multifaceted approach to managing diabetes and promoting better blood glucose control in affected individuals
Are there any specific conditions in which Glimicer MV should not be taken?
It is essential to steer clear of administering Glimicer MV to individuals who have a known hypersensitivity to any of its components or excipients Furthermore patients with moderate to severe kidney dysfunction should refrain from using this medication Similarly individuals who suffer from inflammatory bowel disease colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis should also avoid the use of Glimicer MV These precautions are crucial to ensure the safety and wellbeing of patients as allergic reactions or adverse effects may occur if the medication is used by individuals who fall into these categories Therefore it is imperative for healthcare professionals to thoroughly assess each patients medical history and condition to determine whether Glimicer MV is a suitable treatment option or if an alternative should be considered By adhering to these guidelines healthcare providers can optimize patient care and minimize the risk of potential complications associated with the use of Glimicer MV
What are the possible side effects of Glimicer MV?
Glimicer MV is a medication that like any other may bring about certain side effects The most frequently reported ones include hypoglycemia which is characterized by a low blood sugar level Additionally individuals taking Glimicer MV may experience nausea diarrhea and a change in taste perception Some patients have also reported experiencing flatulence stomach pain headaches skin rashes and respiratory tract infections while using this medication Hypoglycemia is a common occurrence among Glimicer MV users and it is important to monitor blood sugar levels regularly to avoid potentially dangerous situations Nausea and diarrhea may be transient and usually resolve on their own In cases where these symptoms persist or become bothersome consulting a healthcare professional is advised Alterations in taste perception including an unusual taste in the mouth have been reported While this side effect is not typically severe it can affect a persons enjoyment of food and beverages Other gastrointestinal issues such as flatulence and stomach pain have also been associated with Glimicer MV use but are usually of mild to moderate intensity Headaches skin rashes and respiratory tract infections are less common side effects but have been reported If these symptoms occur it is important to consult a healthcare provider for further evaluation It is crucial to note that the occurrence of these side effects varies from person to person and not everyone may experience them If any unexpected or concerning symptoms arise while taking Glimicer MV it is always recommended to seek medical advice for proper assessment and guidance
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
Glimicer MV 2 Tablet SR
Prescription Required
Packaging :
strip of 10 tablet sr
Manufacturer :
Retra Life Science Pvt LtdMRP :
Related Posts
1:15
5 Healthier Sugar Alternatives!
1:15
Pregnancy and Diabetes: What to Eat? | Foods to Eat for Gestational Diabetes!
1:15
3 Practical Tips to Improve Quality of Life for Dementia Patients!
1:15
Vidya Balan's Weight Loss: Proven Tips for Your Dream Body!
1:15
3 lifestyle changes that can help reduce the risk of Dementia!
1:15
The Impact of long term untreated Sleep Apnea on Your Health!
1:15
The dangers of too much caffeine consumption!